Tuomas Kiviniemi profile picture
Tuomas
Kiviniemi
Associate Professor, Internal Medicine
MD, PhD, FESC

Contact

Areas of expertise

Cardiology
Clinical trials
Atrial fibrillation
Coronary artery disease
Percutaneous coronary intervention
Pacemaker
Anticoagulation
Bleeding;

Biography

As a clinical cardiologist with a specific research interest in atrial fibrillation (AF) and long-term complications after percutaneous and surgical procedures, I have established a research group, which includes 10 PhD students at present. From a clinical point of view, my specific focus is AF patients undergoing cardiac procedures.

Teaching

Cardiology, ECG, Echocardiography, Atrial fibrillation, Anticoagulation


Research

PI leads CAREFIB Consortium, which aims to reduce the burden of atrial fibrillation and its adverse outcome stroke in patients undergoing cardiac procedures. This consortium is divided into three major studies: a retrospective epidemiological CAREAVR study; a prospective CAREBANK biobank and a prospective LAA-CLOSURE trial.

Publications

Sort by:

Contemporary radiation doses in interventional cardiology: a nationwide study of patient skin doses in Finland (2019)

Radiation Protection Dosimetry
Jukka Järvinen, Joanna Sierpowska, Teemu Siiskonen, Minna Husso, Hannu Järvinen, Tuomas Kiviniemi, Tuomas T Rissanen, Carita Lindholm, Hanna Matikka, Heli R S Larjava, Timo J Mäkelä, Satu Strengell, Markku Eskola, Teuvo Parviainen, Elina Hallinen, Markku Pirinen, Antti Kivelä, Mika Teräs
(Vertaisarvioitu alkuperäisartikkeli tai data-artikkeli tieteellisessä aikakauslehdessä (A1))

Contemporary radiation doses in interventional cardiology: a nationwide study of patient doses in Finland (2019)

Radiation Protection Dosimetry
Jukka Järvinen, Joanna Sierpowska, Teemu Siiskonen, Hannu Järvinen, Tuomas Kiviniemi, Tuomas T Rissanen, Hanna Matikka, Eini Niskanen, Saija Hurme, Heli R S Larjava, Timo J Mäkelä, Satu Strengell, Markku Eskola, Teuvo Parviainen, Elina Hallinen, Markku Pirinen, Antti Kivelä, Mika Teräs
(Vertaisarvioitu alkuperäisartikkeli tai data-artikkeli tieteellisessä aikakauslehdessä (A1))

Alirocumab and Cardiovascular Outcomes after Acute Coronary Syndrome (2018)

New England Journal of Medicine
Schwartz GG, Steg PG, Szarek M, Bhatt DL, Bittner VA, Diaz R, Edelberg JM, Goodman SG, Hanotin C, Harrington RA, Jukema JW, Lecorps G, Mahaffey KW, Moryusef A, Pordy R, Quintero K, Roe MT, Sasiela WJ, Tamby JF, Tricoci P, White HD, Zeiher AM; ODYSSEY OUTCOMES Committees and Investigators
(Vertaisarvioitu alkuperäisartikkeli tai data-artikkeli tieteellisessä aikakauslehdessä (A1))